Injectable Drug Development
26 experts from the United States and Europe offer both an overview of the basics and an in-depth understanding of this complex area by providing an interdisciplinary approach including pharmaceutics, physiology, anatomy, toxicology, and product formulation.
Chapters Include:
Challenges in the Development of Injectable Products, Mike Akers / Pain, Irritation, and Tissue Damage with Injectables, Wolfgang Klement / Mechanisms of Muscle Damage with Injectable Products, Anne McArdle & Malcolm Jackson / In Vitro Methods for Evaluating Intravascular Hemolysis, Joseph Krzyaniak & Samuel Yalkowsky / Lesion and Edema Models, Steve Sutton / Rat Paw-Lick and Mouse Scratch Models, Pramod Gupta / Radiopharmaceuticals for the Noninvasive Evaluation of Inflammation Following Intramuscular Injections, Agatha Feltus, Michael Jay, & Robert Beihn / A Primer on In Vitro and In Vivo Cytosolic Enzyme Release Methods, Gayle Brazeau / Histological and Morphological Methods, Bruce Carlson & Robert Palmer / A Conscious Rat Model to Assess Pain Upon Intravenous Injection, John Marcek / Co-Solvents in Injectable Formulations, Susan Way & Gayle Brazeau / Pro-Drugs, Laszlo Prokai & Katalin Prokai-Tatrai / Complexation -- Use of Cyclodextrins to Improve Pharmaceutical Properties of Intramuscular Formulations, Marcus Brewster & Thorsteinn Loftsson / Liposomal Formulations to Reduce Irritation of Intramuscularly and Subcutaneously Administered Drugs, F. Kadir, C. Oussoren, & D. Crommelin / Polymeric Microspheres, Elias Fattal / Emulsions, Pramod Gupta & John Cannon / Optimization of Injectable Formulations, Larry Gatlin & Carol Gatlin
Interpharm Press, Inc., 15 Inverness Way E., Englewood, CO 80112-5776. Tel: 303-662-9101; Fax: 303-754-3953.